Evommune (EVMN) Prepaid Assets (2024 - 2026)
Evommune (EVMN) reported Prepaid Assets of $4.4 million for Q1 2026, up 2.64% on a QoQ basis from $4.3 million in Q4 2025.
Evommune (EVMN) has 3 years of Prepaid Assets data on file, last reported at $4.4 million in Q1 2026.
- Quarterly Prepaid Assets changed N/A year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (changed N/A YoY) and the FY2025 annual result came in at $4.3 million, up 119.61% from the prior year.
- Prepaid Assets advanced to $4.4 million in Q1 2026 per EVMN's latest filing, from $4.3 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $5.9 million in Q3 2025 and bottomed at $1.9 million in Q4 2024.
- The 3-year median for Prepaid Assets is $4.3 million (2025), against an average of $4.1 million.
- Peak annual rise in Prepaid Assets reached 119.61% in 2025, while the deepest fall reached 119.61% in 2025.
- Tracing EVMN's Prepaid Assets over 3 years: stood at $1.9 million in 2024, then surged by 119.61% to $4.3 million in 2025, then rose by 2.64% to $4.4 million in 2026.
- Per Business Quant, the three latest EVMN Prepaid Assets figures stand at $4.4 million (Q1 2026), $4.3 million (Q4 2025), and $5.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Evommune | 782.16 Mn | 570.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.39 Mn |
| Dec 31, 2025 | 4.28 Mn |
| Sep 30, 2025 | 5.88 Mn |
| Dec 31, 2024 | 1.95 Mn |